Check if Wegovy is preferred or non-preferred on your specific formulary
RUO Labeling, Product Documentation, and Claim Boundaries RUO labeling, product documentation, and claim boundaries work together
NICE guidance recommends regular monitoring of patients on GLP-1 receptor agonists, including assessment of gastrointestinal tolerability, weight changes, and glycaemic control
The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler
While no major drug interactions between GLP-1 medications and antifungals are known, it's always best to have your healthcare provider or pharmacist review your complete medication list, as GLP-1 agents can affect the absorption of some oral medications by delaying gastric emptying